News • Depth-resolved fiber photometry

Tracking Alzheimer’s progression in real time

Scientists have developed an innovative technique to observe Alzheimer’s disease as it progresses in the brain – an important step forward that could accelerate new treatments.

Photo
Coronal brain slice showing the flat fiber penetration track surrounded by Methoxy-X04-stained amyloid pathology. The white dashed line shows the penetration track. Scale: 1 mm.

Image source: Byron N, McAlinden N, Pisano F et al., Neurophotonics 2025 (CC BY 4.0

The new method uses light to detect and measure the build-up of amyloid plaques – a key characteristic of Alzheimer’s – at different depths in the brain. This is the first time such measurements have been made in living animals as they move naturally, rather than under anaesthetic or in fixed positions. 

The research, published in the journal Neurophotonics, was carried out by the University of Strathclyde in partnership with the Istituto Italiano di Tecnologia, University of Padua, and the Technical University of Denmark, and combines expertise in neuroscience, physics and biomedical imaging. 

A special fluorescent dye that attaches to amyloid plaques in the brain was used, with ultra-thin optical fibres then applied to shine light into the brain and measure how much of the dye was present – giving a clear picture of how much plaque had formed.

The system was tested in mice that had been genetically modified to develop Alzheimer’s-like symptoms. The results closely matched those seen in postmortem brain tissue, confirming that the new technique is accurate. 

Professor Shuzo Sakata at Strathclyde and senior author of the study, said: "Being able to monitor changes in the brain as they happen – in real time and across different brain regions – is a major step forward. It will help researchers understand how Alzheimer’s disease develops and test whether new treatments are working, more quickly and accurately than before." 

The research was funded by the European Union’s Horizon 2020, the Medical Research Council, part of UKRI, and Alzheimer’s Research UK. 

Dr Niall McAlinden, co-author, and an expert in Photonics at Strathclyde, said: “This approach allows us to track the disease over time in the same subject, and opens new doors for studying the progression of Alzheimer’s and how it responds to treatment.” 

The team is now working to improve the system’s capabilities and explore its use in other characteristics of Alzheimer’s disease. 


Source: University of Strathclyde 

09.10.2025

Related articles

Photo

News • In-depth view at neurodegeneration

New 3D imaging approach looks into earliest stages of Alzheimer's

Novel 3D imaging could comprehensively characterize a part of the brain that shows perhaps the earliest accumulation of tau protein, an important biomarker for the development of Alzheimer's disease.

Photo

News •

Down syndrome research untangles therapeutic possibilities for Alzheimer's

More than five million Americans are living with Alzheimer's disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta…

Photo

Article •

The hubs and spokes of brain traffic

New insights into the ways the human brain functions – that is the promise of mapping the entire web of connections in the brain, the so-called connectome. New developments in connectome imaging…

Related products

Subscribe to Newsletter